Advanced Research on Endometriosis and Adenomyosis

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 31 May 2025 | Viewed by 2259

Special Issue Editors


E-Mail Website
Guest Editor
Women’s Hospital, Zhejiang University School of Medicine, No. 1 Xue Shi Road, Hangzhou 310006, China
Interests: endometriosis; adenomyosis

E-Mail Website
Guest Editor
Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong
Interests: reproductive medicine (endometriosis, miscarriage, implantation failure, polycystic ovary syndrome); developmental biology (redox control, gene dosage); maternal medicine (preeclampsia, gestational diabetes mellitus); fetal medicine (fetal hypoxia, preterm, fetal growth restriction)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue of Biomedicines will mainly focus on the research progress of the pathogenesis, diagnosis and treatment of endometriosis.

The pathophysiologies of endometriosis and adenomyosis are extremely similar, and both are common chronic gynecological disorders. However, the pathogenic mechanisms are still unclear, which limits the options of diagnosis and treatment. Therefore, we devote ourselves to agglomerate brilliant ideas and information together from all over the world to form better diagnosis and treatment for the patients with endometriosis or adenomyosis.

We cordially invite authors in the field to submit the research or review articles related to this field of medicine.

Dr. Xinmei Zhang
Prof. Dr. Chi Chiu Wang
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • endometriosis
  • adenomyosis
  • pathogenesis
  • diagnosis and treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 985 KiB  
Review
Diagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights
by Laura Krygere, Povilas Jukna, Kristina Jariene and Egle Drejeriene
Biomedicines 2024, 12(12), 2867; https://doi.org/10.3390/biomedicines12122867 - 17 Dec 2024
Cited by 1 | Viewed by 1573
Abstract
Endometriosis is a common gynecological condition affecting approximately 10% of women of reproductive age, characterized by the abnormal presence of endometrial-like tissue outside the uterus. Although endometriosis was first described over 300 years ago, its underlying mechanisms remain poorly understood, and accurate, prompt [...] Read more.
Endometriosis is a common gynecological condition affecting approximately 10% of women of reproductive age, characterized by the abnormal presence of endometrial-like tissue outside the uterus. Although endometriosis was first described over 300 years ago, its underlying mechanisms remain poorly understood, and accurate, prompt diagnosis continues to be challenging. Currently, there is a lack of effective, non-invasive diagnostic methods, and available treatments often come with significant side effects and high recurrence rates. This has spurred interest in investigating the role of pro- and anti-inflammatory molecules, particularly cytokines, in endometriosis, as these molecules play a key role in its progression by influencing cell growth and differentiation. Previous studies suggest that various cytokines could serve as potential biomarkers for diagnosing endometriosis, as they are detectable in both serum and peritoneal fluid. This review provides an overview of the expression, origin, function, and regulation of specific cytokines in endometriosis, along with a brief discussion on their potential clinical implications for diagnosis. Due to the complexity of endometriosis, a panel of multiple biomarkers may ultimately be necessary for accurate diagnosis. It is essential to consider factors such as patient selection, sample collection, and analytical variability when initiating or evaluating biomarker studies. Full article
(This article belongs to the Special Issue Advanced Research on Endometriosis and Adenomyosis)
Show Figures

Figure 1

Back to TopTop